The Lebanese COVID-19 Cohort; A Challenge for the ABO Blood Group System.
ABO
COVID-19
MENA (Middle East and North Africa)
SARS–CoV-2
infection predisposition
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2020
2020
Historique:
received:
20
07
2020
accepted:
20
10
2020
entrez:
17
12
2020
pubmed:
18
12
2020
medline:
18
12
2020
Statut:
epublish
Résumé
A sudden outbreak of pneumonia caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has rapidly spread all over the world facilitating the declaration of the resultant disease as a pandemic on March 2020. Predisposing factors for acquiring COVID-19 and for developing a severe form of this disease were postulated to be related to the epidemiological, clinical, and genetic characteristics of the patients. Biological markers such as the ABO blood group system were amongst these factors that were proposed to be linked to the variability in the disease course and/or the prevalence of the infection among different groups. Herein, we conducted the first retrospective case-control study from the Middle East and North Africa that tackles the association between the blood group types and the susceptibility to, as well as the severity of, SARS-CoV-2 infection. Contrary to the most acknowledged hypothesis, our results challenged the significance of this association and questioned the role of the ABO blood group system in dictating the severity of this disease. For future similar studies, we endorsed analyzing larger cohorts among different populations and we encouraged implementing more rigorous approaches to diminish the potential confounding effect of some underlying comorbidities and genetic variants that are known to be associated with the ABO blood group system.
Identifiants
pubmed: 33330542
doi: 10.3389/fmed.2020.585341
pmc: PMC7715023
doi:
Types de publication
Journal Article
Langues
eng
Pagination
585341Informations de copyright
Copyright © 2020 Khalil, Feghali and Hassoun.
Références
Iran J Pathol. 2020 Summer;15(3):156-160
pubmed: 32754209
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Int J Surg. 2020 Apr;76:71-76
pubmed: 32112977
Clin Infect Dis. 2020 Aug 04;:
pubmed: 32750119
Blood Transfus. 2013 Oct;11(4):491-9
pubmed: 24120598
Clin Chim Acta. 2020 Oct;509:220-223
pubmed: 32562665
Eur J Prev Cardiol. 2020 Sep;27(13):1436-1437
pubmed: 32343152
Clin Transl Med. 2020 Feb 20;9(1):19
pubmed: 32078069
Front Immunol. 2020 May 28;11:1248
pubmed: 32574274
Clin Microbiol Infect. 2020 Jun;26(6):767-772
pubmed: 32304745
Br J Haematol. 2020 Jul;190(2):e93-e94
pubmed: 32453863
Br J Haematol. 2020 Jul;190(1):24-27
pubmed: 32379894
N Engl J Med. 2020 Oct 15;383(16):1522-1534
pubmed: 32558485
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Transfus Apher Sci. 2020 Oct;59(5):102838
pubmed: 32513613
Eur J Prev Cardiol. 2020 Aug;27(12):1331-1332
pubmed: 32460534
Nat Commun. 2020 Nov 13;11(1):5761
pubmed: 33188185
J Med Liban. 2001 May-Jun;49(3):140-2
pubmed: 12184458
Int J Soc Psychiatry. 2020 Nov;66(7):666-674
pubmed: 32489136
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
Front Med (Lausanne). 2020 Jun 05;7:286
pubmed: 32582740